ALX Oncology Holdings INC
SEC CIK 1810182 · ALXO · last insider filing 2026-04-17
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Klencke Barbara | Director · Chief Medical Officer | filed 2025 - 2026 |
| Lettmann Jason | Director · Chief Executive Officer | filed 2020 - 2026 |
| Goodman Corey S | Director | filed 2020 - 2026 |
| Garland J. Scott | Director | filed 2022 - 2026 |
| Takimoto Chris H | Director | filed 2025 - 2026 |
| Hemrajani Rekha | Director | filed 2020 - 2026 |
| Sandler Alan B. | Director · Chief Medical Officer | filed 2024 - 2026 |
| Curran Daniel J. | Director | filed 2025 - 2026 |
| Pons Jaume | Director · President and CEO | filed 2020 - 2025 |
| Randolph Sophia | Director · Chief Medical Officer | filed 2020 - 2024 |
| Nielsen Jack | Director | filed 2020 - 2023 |
| Canamasas Itziar | Director | filed 2022 - 2023 |
| Graham G. Walmsley | Director | filed 2020 - 2021 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Knight Jeff E. | Chief Dev & Operating Officer | filed 2026 - 2026 |
| Pinto Shelly | VP, Finance and CAO | filed 2021 - 2026 |
| Shantharam Harish | Chief Financial Officer | filed 2025 - 2026 |
| Garcia Peter S | Chief Financial Officer | filed 2020 - 2024 |
| Pietzke Steffen | VP Fin & Chief Acct Officer | filed 2020 - 2020 |
| Caffo Nathan | Chief Business Officer | filed 2020 - 2020 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.